Pharmaceutical Executive July 16, 2024
The latest news for pharma industry insiders.
What Sponsors Can Expect From FDA’s Diversity Action Plan Guidance
Del Smith, PhD, co-founder & CEO of Acclinate highlights challenges sponsors may face in light of FDA releasing its Diversity Action Plan guidance.
A New Class of Medicine for Pain Relief On The Horizon
Developed by Vertex Pharmaceuticals, suzetrigine is a promising new class of pain medicine that has been gaining attention for its innovative mechanism of action and reported efficacy; suzetrigine might offer hope for those struggling with acute pain issues who want to avoid opioids and NSAIDs.
Universities Don’t Want AI Research to Leave Them Behind
Outspent by Big Tech, some academics are focusing on research that requires less computing power,...
Today's Sponsors
Today's Sponsor